lynn malec
@malecly
Followers
483
Following
431
Media
22
Statuses
131
pediatric/adult hematologist with hemophilia focus, passionate to improve care for women/girls with bleeding disorders, clinical researcher, proud cheesehead
Wauwatosa, WI
Joined March 2011
Proud of this study and the data it provides for peds hemophilia A patients as we strive for optimal health ❤️💉🩸 Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A | New England Journal of Medicine
nejm.org
Once-weekly efanesoctocog alfa provides high sustained factor VIII activity with superior bleeding prevention as compared with prestudy factor VIII prophylaxis in previously treated patients 12 yea...
2
7
29
Joshua Muia kicking off #HTRS2025 Research Colloquium sharing how @HTRStoday help build careers in hemostasis and thrombosis.
0
1
9
Lynn Malec presents the latest from the XTEND-ed Phase 3 study! The second interim analysis reveals two-year clinical outcomes of once-weekly efanesoctocog alfa #prophylaxis in children with severe #haemophilia A. How does it impact bleed control and quality of life? #EAHAD2025
0
1
3
Me watching the votes roll in while my 7 y.o. exercises her Montessorian muscles tracking the electoral map
0
0
7
Montgomery Educational Symposium on Hemostasis (MESH) was a huge success thanks to the incredibly bright minds and warm hearts that gathered to honor ‘Montgomery, Milwaukee’s’ amazing career @VersitiResearch
1
5
25
Such a great experience to partner with @pjlynch on this episode 🎙️ ALWAYS more to learn! Staying curious drives improvements for patients 👏🏼
If experts like Dr. Lynn Malec are still learning about #jointhealth and #hemophilia, think about how much there is still to learn, and account for, for most patients.
0
0
4
If experts like Dr. Lynn Malec are still learning about #jointhealth and #hemophilia, think about how much there is still to learn, and account for, for most patients.
New insights from the EXTEND study reveal improved hemophilia joint health scores! Learn more in our latest episode of Global Hemophilia Report. https://t.co/MRz7jBwUqW Featured Advertiser: @SanofiUS
1
1
16
Expanded space, expanded collaborations, expanded discoveries
Versiti begins $79M expansion in Wauwatosa, but funding still needed - Milwaukee Business Journal https://t.co/txuNN4njd5 via @MKEBizJournal
0
0
7
It is time for one of the most famous slides in #hemophilia to be updated. Paper in @JTHjournal describes prospectively collected bleeding rate data in 825 children with mild hemophilia. https://t.co/WelYY49itV
0
14
41
Check out publication by VBRI Senior investigator Qizhen Shi @QizhenShi and collaborators Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia…
pubmed.ncbi.nlm.nih.gov
Anti-factor VIII (FVIII) antibody development poses a significant challenge in hemophilia A (HA) patients receiving FVIII protein replacement therapy. There is an urgent need for novel therapeutic...
1
3
4
Interested in a Hematology position at Versiti? My biased opinion is our team is phenomenal 😉 Associate Medical Director/Medical Director, Versiti Medical Sciences Institute/CCBD- Adult and/or Med/Peds Hematologist (#Milwaukee, Wisconsin) #job
0
2
3
So well deserved! @JuliPerezBot you are amazing!
Congrats to @JuliPerezBot, who was named an Exceptional Woman in Medicine by @MKElifestyle. Learn more about her work: https://t.co/lmnGvKXZUw
#VersitiResearch #VersitiScience #MKElifestyle
0
0
10
So great to participate in this collaboration! Always inspiring to work/present along side you 👊🏼💜
0
0
9
A pediatric legend and the heart and soul of @residentsofchp . Dena taught us every day by example and with sage advice that led to a generation of Pittsburgh Pediatricians. She will be missed.
We would like to remember and honor the memory of Dr. Dena Hofkosh, Emeritus Professor of Pediatrics, who passed Tuesday morning. She will be greatly missed by all. Please read Dr. Dermody's message here: https://t.co/R6PuoC3NI3
@ChildrensPgh @UPMCPhysicianEd @PittHealthSci
0
5
35
Exciting work from Zheng lab!
Hope this review article give you the aha moments that it gave us when we wrote it. @DrWenDai1
0
0
4
Gene therapy for hemophilia A has arrived in the US. U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe Hemophilia A
prnewswire.com
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today...
1
2
4
In an editorial in @haemophilia_jnl Hermans and Pierce discuss the recent advances in #hemophilia treatments and look forward to the time when affected individuals can lead a life with no hinderance from the disease. https://t.co/WPp5CUUPvI
1
12
26
Was so great to honor Dr. Ritchey during his Distinguishing Career Award ceremony and fun celebrations with Pittsburgh and ASPHO colleagues @DrFriehling @PedsHemeOncPGH
1
2
18
@Versiti Gala Awards Dinner - Bob Montgomery won the Greenwald award !!! Congratulations Bob! 🎈🎈🎈🎈thanks to Chris Miskel our CEO @BloodResearchWI
1
7
36